Rio Grande City Nursing Center: Medication Record Failures - TX
The November 2025 complaint inspection found that Resident 1 had received a 5 mg/ml dose of Haldol, the brand name for Haloperidol lactate, without the administration being documented on his electronic medication record. Haloperidol is an antipsychotic drug used to treat conditions including schizophrenia and acute agitation. It carries serious risks, including movement disorders and, in elderly patients with dementia, an increased risk of death.
The Assistant Director of Nursing, a licensed vocational nurse, had written a progress note stating the medication was given. When inspectors raised the missing signature on the medication administration record, management pointed to that progress note and said it was enough. There was, management told inspectors, no negative outcome from the missing documentation.
That reasoning is the problem inspectors documented.
A medication administration record is not a formality. It is the primary tool nurses use to verify what a patient has or has not received. When a nurse prepares to give a medication, the first step is checking the record. If a prior dose was never signed off, the record looks the same as if the dose was never given. A second nurse working a later shift, or responding to a change in a resident's condition, cannot tell from the record whether the medication was administered or skipped entirely.
The facility's own medication administration policy, last updated in October 2022, states plainly that nurses are required to sign the medication administration record after administering a medication. The policy exists precisely because a progress note buried in a chart is not a substitute for a clear, contemporaneous entry in the record designed for that purpose.
Management's response to inspectors, that no harm resulted, missed the point entirely. The risk created by an unsigned medication record is not just the risk that the resident was harmed in that specific instance. It is the risk that the next person caring for that resident cannot accurately account for what he has received. With a drug like Haloperidol, that gap matters. Giving a second dose because the first was never documented could cause serious harm. Withholding a dose because staff assumed the unsigned record meant it had not been given could also cause harm.
The inspection cited the deficiency under F0755, which covers medication administration, and rated the level of harm as minimal harm or potential for actual harm, with few residents affected. That rating reflects what inspectors found in this specific complaint, not a conclusion that the documentation practice was harmless.
What the inspection captured was not a nurse who skipped a medication or gave the wrong dose. It was a facility where, when a documentation failure was identified, the administrative response was to explain it away rather than treat it as a problem worth correcting. The ADON told inspectors there was no negative outcome. The facility pointed to the progress note. Nobody, in the account inspectors documented, said the signature should have been there and wasn't.
That posture matters as much as the underlying lapse. Documentation failures in medication administration tend not to be isolated events. They reflect habits, and habits reflect what a workplace treats as acceptable. When the person responsible for nursing oversight tells a federal inspector that an unsigned medication record is acceptable because a progress note exists, that is a statement about institutional standards.
Resident 1 received his Haldol. That much appears to be true. Whether the next resident, on the next shift, with a different nurse checking a record that looks identical to one where the medication was never given, will be as fortunate is a question the progress note cannot answer.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Rio Grande City Nursing and Rehabilitation Center from 2025-11-20 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: This article is based on inspection data downloaded directly from the Centers for Medicare & Medicaid Services (CMS) via Medicare.gov. CMS releases inspection reports in bulk; we publish the findings as documented by state surveyors in the official Form CMS-2567 Statement of Deficiencies.
Plan of correction: The CMS report we receive does not include the facility's plan of correction. Facilities submit plans of correction separately to state survey agencies and those responses may not be reflected in CMS data at the time of publication. The absence of a plan of correction in our data does not mean one was not filed. Readers who want information about corrective steps taken are encouraged to contact the facility directly or their state survey agency.
Corrections may have occurred: Inspection reports reflect conditions observed on the date of the survey. Facilities may have implemented corrections, staffing changes, additional training, or other remediation since the report was issued. We report what CMS provides and encourage readers to seek current information from the facility.
Editorial process: Inspection findings are extracted from CMS source documents and synthesized using AI, reviewed for factual accuracy against the original report by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: August 29, 2026 · Our methodology
RIO GRANDE CITY NURSING AND REHABILITATION CENTER in RIO GRANDE CITY, TX was cited for violations during a health inspection on November 20, 2025.
Haloperidol is an antipsychotic drug used to treat conditions including schizophrenia and acute agitation.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.